Share Name Share Symbol Market Type Share ISIN Share Description
York Pharma LSE:YRK London Ordinary Share GB00B00QHC86 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.25p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 2.00

York Pharma (YRK) Latest News

Real-Time news about York Pharma (London Stock Exchange): 0 recent articles
More York Pharma News
York Pharma Takeover Rumours

York Pharma (YRK) Share Charts

1 Year York Pharma Chart

1 Year York Pharma Chart

1 Month York Pharma Chart

1 Month York Pharma Chart

Intraday York Pharma Chart

Intraday York Pharma Chart

York Pharma (YRK) Discussions and Chat

York Pharma Forums and Chat

Date Time Title Posts
13/8/200910:10York Pharma - a hot pharma for 20052,999
03/3/200915:54BOMBED OUT STOCK THAT COULD EXPLODE IN 200916
14/11/200416:36new issue2
14/11/200415:47York Pharma - New to the Market : 26th April 2004140
10/9/200415:40mile-

Add a New Thread

York Pharma (YRK) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all York Pharma trades in real-time

York Pharma (YRK) Top Chat Posts

DateSubject
01/10/2016
09:20
York Pharma Daily Update: York Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker YRK. The last closing price for York Pharma was 3.25p.
York Pharma has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 61,399,715 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of York Pharma is £1,995,490.74.
18/6/2009
14:37
topinfo: KiKi...Not long to wait now, they will be back soon. Just remember this was priced to go bust, either we get fully taken over or Re-Financed, either way share price will go up significantly. Looking at ULU I would rather go for the re-financing deal and that way the new CEO Richard Anderson who is the biggest single shareholder can rebuild the business and return real value to shareholders. If it comes back then it will be one of two deals as mentioned, either or will have massive impact on share price I personally would like to see option 2.
07/6/2009
08:04
kiki14p: Thanks Topinfo & BB80 reassuring comments..Not spoken to RA but heard it all before from previous CEO... TS in conversation was also very very optimistic about the company (maybe too much!) - won't again base my investment decisions on how enthusiastic a director is, does not mean they can pull it off and grow the company and share price on enthusiasm alone!
02/3/2009
16:29
ursamajorra: RNS Number : 1570O York Pharma plc 02 March 2009 ? Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan or the Republic of Ireland York Pharma plc (the "Company") Statement concerning Possible Offer and Rule 2.10 announcement The Board of the Company notes the recent movement in the Company's share price and confirms that the Company has made an approach to a potential offeror which may or may not lead to an offer being made for the Company. The Board of the Company, which is being advised by Collins Stewart Europe Limited, wishes to stress that these discussions are at a very early stage and there can be no certainty that this approach will lead to an offer being made for the Company.
22/12/2008
11:12
handycam: Sinclair and York are two very similar peas in a pod, though the former has a reasonable business it would seem. Share price trajectories are carbon copies.
19/12/2008
09:50
smelleroo: wetdream, i fully agree that the share price has discounted abasol, but why would it not be approved by the mhra? smell
09/12/2008
20:09
bignads: Handycam. That question did cross my mind. However, I would imagine there are a few people willing to sell given the collapse in the share price over the last eighteen months, so it's hardly surprising. To be honest, If I get it wrong I'm going to lose 15 pence max. if I get it right, I stand to make 45 pence per share minimum. I see the two scenarios as equal risk, so that's not a bad position to be in. What's your view of fair value. 5p?
09/12/2008
14:10
bignads: Oh, well, I've dipped my toe in the water. 20,000 at 15 pence seems like a steal to me. believe the latest 6-month results should be a boost to the share price as revenues start to feed into the bottom line. Not expecting profits just yet, but reduced losses and a positive outlook from the firm should do it...
02/10/2008
18:28
kiki14p: there has been little development news this year... Abasol approval would be nice for the share price along with a US licencing deal.....here's hoping they finally arrive soon!
17/9/2008
22:10
topvest: you bet - still no news and the share price graph looks like it is heading to zero!
18/7/2008
20:47
topvest: OOPS...looks like they are having problems raising the money now the share price has fallen.
York Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161001 08:45:45